OrthoLazer, a Warsaw, IN-based provider of MLS M8 Robotic Laser therapy for treatment of orthopedic pain and inflammation, raised $7M in Series A funding.
Backers were not disclosed.
The company intends to use the funds to accelerate its expansion plans, including the addition of innovative orthopedic wellness treatments, and enhance its ability to deliver non-invasive pain management solutions to more patients.
Founded by CMO Dr. Scott Sigman and led by CEO Rod Mayer, OrthoLazer is a provider of a healthcare company specializing in advanced laser therapy for orthopedic conditions. Utilizing FDA-cleared laser technology, it provides non-invasive, opioid-free pain management solutions aimed at improving patient recovery times and outcomes.
The company is dedicated to transforming the landscape of orthopedic care and offering effective treatment options for patients.
FinSMEs
23/10/2024